ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

INZY Inozyme Pharma Inc

4.88
0.00 (0.00%)
プレマーケット
最終更新日: 20:00:11
15分遅延
名称 銘柄コード 市場 種別
Inozyme Pharma Inc INZY NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 4.88 20:00:11
始値 安値 高値 終値 前日終値
4.88
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0321:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2024/4/0819:30GLOBEInozyme Pharma Announces Positive Topline Data from Ongoing..
2024/4/0607:00GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2024/4/0221:30GLOBEInozyme Pharma to Participate at the 23rd Annual Needham..
2024/3/2621:30GLOBEInozyme Pharma to Report Topline Data from Ongoing Phase 1/2..
2024/3/1221:30GLOBEInozyme Pharma Reports Full Year 2023 Financial Results and..
2024/2/2622:30GLOBEInozyme Pharma to Participate in the TD Cowen 44th Annual..
2024/2/1422:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1311:06EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/0622:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2023/12/0522:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2023/11/1614:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/0922:30GLOBEInozyme Pharma to Participate in Upcoming Investor..
2023/11/0806:07EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0722:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0722:31EDGAR2Form 8-K - Current report
2023/11/0722:30GLOBEInozyme Pharma Reports Third Quarter 2023 Financial Results..
2023/11/0405:15GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2023/10/2621:30GLOBEInozyme Pharma Announces Presentation at the American..
2023/10/1021:30GLOBEInozyme Pharma Highlights Inclusion of Generalized Arterial..
2023/10/0621:30GLOBEInozyme Pharma Announces Three Poster Presentations at the..
2023/10/0405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2705:12EDGAR2Form 8-K - Current report
2023/9/2620:30GLOBEInozyme Pharma Announces Positive Interim Data from Ongoing..
2023/9/2021:30GLOBEInozyme Pharma to Host Virtual Investor and Analyst Event on..
2023/9/0621:30GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2023/9/0521:30GLOBEInozyme Pharma to Present at the H.C. Wainwright 25th Annual..
2023/8/1205:08EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/0822:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0821:37EDGAR2Form 8-K - Current report
2023/8/0821:30GLOBEInozyme Pharma Reports Second Quarter 2023 Financial Results..
2023/8/0810:58EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/8/0409:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0405:01GLOBEInozyme Pharma Reports Inducement Grants Under Nasdaq..
2023/8/0205:01GLOBEInozyme Pharma, Inc. Announces Closing of Public Offering of..
2023/7/2906:19EDGAR2Form 8-K - Current report
2023/7/2906:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/2812:20GLOBEInozyme Pharma, Inc. Announces Pricing of Public Offering of..
2023/7/2806:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/7/2805:33GLOBEInozyme Pharma, Inc. Announces Proposed Offering of Common..
2023/7/2620:42EDGAR2Form 8-K - Current report
2023/7/2620:30GLOBEInozyme Pharma Announces Updates on Global Development..
2023/7/1921:30GLOBEInozyme Pharma to Provide ENPP1 Deficiency Program Update on..
2023/6/2721:30GLOBEInozyme Pharma Announces Dosing of First Infant with ENPP1..
2023/6/0220:30GLOBEInozyme Pharma to Present at the Jefferies Healthcare..
2023/5/0921:30GLOBEInozyme Pharma Reports First Quarter 2023 Financial Results..

最近閲覧した銘柄

Delayed Upgrade Clock